Interestingly, the podoplanin-mediated resistance of cancer cells to EGFR tyrosine kinase inhibitors depended on its cytoplasmic domain and required direct contact between CAFs and cancer cells [197], but the molecular mechanism for this effect remains to be elucidated. Here, EGFR is linked to cancer.